Genetics of SLE: Functional relevance for monocytes/macrophages in disease

Clinical and Developmental Immunology

Volumn 2012, Issue , 2012, Pages

  Byrne, Jennifer C ^a   Ní Gabhann, Joan ^a   Lazzari, Elisa ^a   Mahony, Rebecca ^a   Smith, Siobhán ^a   Stacey, Kevin ^a   Wynne, Claire ^a   Jefferies, Caroline A ^a  

^a ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; EXONUCLEASE; FC RECEPTOR; INTERFERON; INTERFERON REGULATORY FACTOR 5; NUCLEIC ACID; STAT4 PROTEIN; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 7; TREX1 PROTEIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA INDUCED PROTEIN 3; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; UNCLASSIFIED DRUG;

ANTIGEN ANTIBODY COMPLEX; COMPLEMENT SYSTEM; DISEASE PREDISPOSITION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETICS; HUMAN; IMMUNOREGULATION; INNATE IMMUNITY; MACROPHAGE; MOLECULAR RECOGNITION; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; SYSTEMIC LUPUS ERYTHEMATOSUS; ANIMAL; IMMUNOLOGY;

ANIMALS; HUMANS; IMMUNITY, INNATE; LUPUS ERYTHEMATOSUS, SYSTEMIC; MACROPHAGES; MONOCYTES;

EID: 84871378070     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2012/582352     Document Type: Review

References (162)

1. Helmick C. G., Felson D. T., Lawrence R. C., Gabriel S., Hirsch R., Kwoh C. K., Liang M. H., Kremers H. M., Mayes M. D., Merkel P. A., Pillemer S. R., Reveille J. D., Stone J. H., Estimates of the prevalence of arthritis and other rheumatic conditions in the United States-part I. Arthritis & Rheumatism 2008 58 1 15 25 2-s2.0-38149138096 10.1002/art.23177
2. Peng S. L., Altered T and B lymphocyte signaling pathways in lupus. Autoimmunity Reviews 2009 8 3 179 183 2-s2.0-58149477394 10.1016/j.autrev.2008. 07.040
3. Kavai M., Szegedi G., Immune complex clearance by monocytes and macrophages in systemic Lupus erythematosus. Autoimmunity Reviews 2007 6 7 497 502 2-s2.0-34447518990 10.1016/j.autrev.2007.01.017 (Pubitemid 47069975)
4. Rönnblom L., Eloranta M. L., Alm G. V., The type I interferon system in systemic Lupus erythematosus. Arthritis & Rheumatism 2006 54 2 408 420 2-s2.0-32444451688 10.1002/art.21571 (Pubitemid 43228615)
5. Sestak A. L., Fürnrohr B. G., Harley J. B., Merrill J. T., Namjou B., The genetics of systemic Lupus erythematosus and implications for targeted therapy. Annals of the Rheumatic Diseases 2011 70 1, supplement i37 i43 2-s2.0-79953035759 10.1136/ard.2010.138057
6. Davies K. A., Schifferli J. A., Walport M. J., Complement deficiency and immune complex disease. Springer Seminars in Immunopathology 1994 15 4 397 416 2-s2.0-0028029158 (Pubitemid 24040808)
7. Korb L. C., Ahearn J. M., C1q binds directly and specifically to surface blebs of apoptotic human keratinocytes: complement deficiency and systemic Lupus erythematosus revisited. Journal of Immunology 1997 158 10 4525 4528 2-s2.0-0031569975 (Pubitemid 127483768)
8. Pickering M. C., Walport M. J., Links between complement abnormalities and systemic Lupus erythematosus. Rheumatology 2000 39 2 133 141 2-s2.0-0034007104 (Pubitemid 30139345)
9. Patole P. S., Gröne H. J., Segerer S., Ciubar R., Belemezova E., Henger A., Kretzler M., Schlöndorff D., Anders H. J., Viral double-stranded RNA aggravates lupus nephritis through toll-like receptor 3 on glomerular mesangial cells and antigen-presenting cells. Journal of the American Society of Nephrology 2005 16 5 1326 1338 2-s2.0-23944497673 10.1681/ASN.2004100820 (Pubitemid 41716517)
10. Lee P. Y., Kumagai Y., Li Y., Takeuchi O., Yoshida H., Weinstein J., Kellner E. S., Nacionales D., Barker T., Kelly-Scumpia K., Van Rooijen N., Kumar H., Kawai T., Satoh M., Akira S., Reeves W. H., TLR7-dependent and Fc γ R-independent production of type I interferon in experimental mouse lupus. Journal of Experimental Medicine 2008 205 13 2995 3006 2-s2.0-59649107055 10.1084/jem.20080462
11. Christensen S. R., Kashgarian M., Alexopoulou L., Flavell R. A., Akira S., Shlomchik M. J., Toll-like receptor 9 controls anti-DNA autoantibody production in murine lupus. Journal of Experimental Medicine 2005 202 2 321 331 2-s2.0-22944490869 10.1084/jem.20050338 (Pubitemid 41043827)
12. Namjou B., Choi C. B., Harley I. T., Evaluation of TRAF6 in a large multiancestral lupus cohort. Arthritis & Rheumatism 2012 64 6 1960 1969
13. Sigurdsson S., Nordmark G., Göring H. H. H., Lindroos K., Wiman A. C., Sturfeit G., Jönsen A., Rantapää-Dahlqvist S., Möller B., Kere J., Koskenmies S., Widén E., Eloranta M. L., Julkunen H., Kristjansdottir H., Steinsson K., Alm G., Rönnblom L., Syvänen A. C., Polymorphisms in the tyrosine kinase 2 and interferon regulatory factor 5 genes are associated with systemic Lupus erythematosus. American Journal of Human Genetics 2005 76 3 528 537 2-s2.0-13844292408 10.1086/428480 (Pubitemid 40250533)
14. Dall'Era M. C., Cardarelli P. M., Preston B. T., Witte A., Davis J. C., Type I interferon correlates with serological and clinical manifestations of SLE. Annals of the Rheumatic Diseases 2005 64 12 1692 1697 2-s2.0-27944464836 10.1136/ard.2004.033753 (Pubitemid 41667141)
15. Hashimoto M., Hirota K., Yoshitomi H., Maeda S., Teradaira S., Akizuki S., Prieto-Martin P., Nomura T., Sakaguchi N., Köhl J., Heyman B., Takahashi M., Fujita T., Mimori T., Sakaguchi S., Complement drives Th17 cell differentiation and triggers autoimmune arthritis. Journal of Experimental Medicine 2010 207 6 1135 1143 2-s2.0-77953497686 10.1084/jem.20092301
16. Zhang Y., Liu S., Yu Y., Zhang T., Liu J., Shen Q., Cao X., Immune complex enhances tolerogenecity of immature dendritic cells via Fc γ RIIb and promotes Fc γ RIIb-overexpressing dendritic cells to attenuate lupus. European Journal of Immunology 2011 41 4 1154 1164 2-s2.0-79953047121 10.1002/eji.201040767
17. Topaloglu R., Bakkaloglu A., Slingsby J. H., Mihatsch M. J., Pascual M., Norsworthy P., Morley B. J., Saatci U., Schifferli J. A., Walport M. J., Molecular basis of hereditary C1q deficiency associated with SLE and IgA nephropathy in a Turkish family. Kidney International 1996 50 2 635 642 2-s2.0-9444254614 (Pubitemid 26274395)
18. Petry F., Molecular basis of hereditary C1q deficiency. Immunobiology 1998 199 2 286 294 2-s2.0-0031687525 (Pubitemid 28404348)
19. Loos M., Heinz H. P., Component deficiencies-1. The first component: C1q, C1r, C1s. Progress in Allergy 1986 39 212 231 2-s2.0-0022924380 (Pubitemid 17009954)
20. Chevailler A., Drouet C., Ponard D., Alibeu C., Suraniti S., Carrere F., Renier G., Hurez D., Colomb M. G., Non-coordinated biosynthesis of early complement components in a deficiency of complement proteins C1r and C1s. Scandinavian Journal of Immunology 1994 40 4 383 388 2-s2.0-0027992608 10.1111/j.1365-3083.1994.tb03478.x (Pubitemid 24311257)
21. Zervou M. I., Vazgiourakis V. M., Yilmaz N., TRAF1/C5, eNOS, C1q, but not STAT4 and PTPN22 gene polymorphisms are associated with genetic susceptibility to systemic lupus erythematosus in Turkey. Human Immunology 2011 72 12 1210 1213
22. Morgan B. P., Walport M. J., Complement deficiency and disease. Immunology Today 1991 12 9 301 306 2-s2.0-0025874771
23. Wu Y. L., Hauptmann G., Viguier M., Yu C. Y., Molecular basis of complete complement C4 deficiency in two North-African families with systemic Lupus erythematosus. Genes and Immunity 2009 10 5 433 445 2-s2.0-67849099265 10.1038/gene.2009.10
24. Yang Y., Chung E. K., Zhou B., Lhotta K., Hebert L. A., Birmingham D. J., Rovin B. H., Yu C. Y., The intricate role of complement component C4 in human systemic Lupus erythematosus. Current Directions in Autoimmunity 2004 7 98 132 2-s2.0-1442288762
25. Shen N., Fu Q., Deng Y., Sex-specific association of X-linked Toll-like receptor 7 (TLR7) with male systemic Lupus erythematosus. Proceedings of the National Academy of Sciences of the United States of America 2010 107 36 15838 15843
26. Kawasaki A., Furukawa H., Kondo Y., Ito S., Hayashi T., Kusaoi M., Matsumoto I., Tohma S., Takasaki Y., Hashimoto H., Sumida T., Tsuchiya N., TLR7 single-nucleotide polymorphisms in the 3' untranslated region and intron 2 independently contribute to systemic Lupus erythematosus in Japanese women: a case-control association study. Arthritis Research and Therapy 2011 13 2, article R41 2-s2.0-79952461669 10.1186/ar3277
27. dos Santos B. P., Valverde J. V., Rohr P., TLR7/8/9 polymorphisms and their associations in systemic Lupus erythematosus patients from southern Brazil. Lupus 2012 21 3 302 309
28. Tao K., Fujii M., Tsukumo S. I., Maekawa Y., Kishihara K., Kimoto Y., Horiuchi T., Hisaeda H., Akira S., Kagami S., Yasutomo K., Genetic variations of Toll-like receptor 9 predispose to systemic Lupus erythematosus in Japanese population. Annals of the Rheumatic Diseases 2007 66 7 905 909 2-s2.0-34347262069 10.1136/ard.2006.065961 (Pubitemid 46999791)
29. Xu C. J., Zhang W. H., Pan H. F., Li X. P., Xu J. H., Ye D. Q., Association study of a single nucleotide polymorphism in the exon 2 region of toll-like receptor 9 (TLR9) gene with susceptibility to systemic Lupus erythematosus among Chinese. Molecular Biology Reports 2009 36 8 2245 2248 2-s2.0-70350323680 10.1007/s11033-008-9440-z
30. Fu Q., Zhao J., Qian X., Wong J. L. H., Kaufman K. M., Yu C. Y., Howe H. S., Mok M. Y., Harley J. B., Guthridge J. M., Song Y. W., Cho S. K., Bae S. C., Grossman J. M., Hahn B. H., Arnett F. C., Shen N., Tsao B. P., Association of a functional IRF7 variant with systemic Lupus erythematosus. Arthritis & Rheumatism 2011 63 3 749 754 2-s2.0-79953707345 10.1002/art.30193
31. Musone S. L., Taylor K. E., Lu T. T., Nititham J., Ferreira R. C., Ortmann W., Shifrin N., Petri M. A., Ilyas Kamboh M., Manzi S., Seldin M. F., Gregersen P. K., Behrens T. W., Ma A., Kwok P. Y., Criswell L. A., Multiple polymorphisms in the TNFAIP3 region are independently associated with systemic Lupus erythematosus. Nature Genetics 2008 40 9 1062 1064 2-s2.0-50449103533 10.1038/ng.202
32. Fan Y., Tao J. H., Zhang L. P., Li L. H., Ye D. Q., The association between BANK1 and TNFAIP3 gene polymorphisms and systemic Lupus erythematosus: a meta-analysis. International Journal of Immunogenetics 2011 38 2 151 159 2-s2.0-79952145856 10.1111/j.1744-313X.2010.00990.x
33. Cai L. Q., Wang Z. X., Lu W. S., Han J. W., Sun L. D., Du W. H., Zhang S. M., Zuo X. B., Zhang X. J., Yang S., A single-nucleotide polymorphism of the TNFAIP3 gene is associated with systemic Lupus erythematosus in Chinese Han population. Molecular Biology Reports 2010 37 1 389 394 2-s2.0-77949275194 10.1007/s11033-009-9818-6
34. Bates J. S., Lessard C. J., Leon J. M., Nguyen T., Battiest L. J., Rodgers J., Kaufman K. M., James J. A., Gilkeson G. S., Kelly J. A., Humphrey M. B., Harley J. B., Gray-McGuire C., Moser K. L., Gaffney P. M., Meta-analysis and imputation identifies a 109kb risk haplotype spanning TNFAIP3 associated with lupus nephritis and hematologic manifestations. Genes and Immunity 2009 10 5 470 477 2-s2.0-67849116005 10.1038/gene.2009.31
35. Han J. W., Zheng H. F., Cui Y., Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic Lupus erythematosus. Nature Genetics 2009 41 11 1234 1237
36. Gateva V., Sandling J. K., Hom G., Taylor K. E., Chung S. A., Sun X., Ortmann W., Kosoy R., Ferreira R. C., Nordmark G., Gunnarsson I., Svenungsson E., Padyukov L., Sturfelt G., Jönsen A., Bengtsson A. A., Rantapää-Dahlqvist S., Baechler E. C., Brown E. E., Alarcón G. S., Edberg J. C., Ramsey-Goldman R., McGwin G., Reveille J. D., Vilá L. M., Kimberly R. P., Manzi S., Petri M. A., Lee A., Gregersen P. K., Seldin M. F., Rönnblom L., Criswell L. A., Syvänen A. C., Behrens T. W., Graham R. R., A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic Lupus erythematosus. Nature Genetics 2009 41 11 1228 1233 2-s2.0-70350650472 10.1038/ng.468
37. Hellquist A., Sandling J. K., Zucchelli M., Koskenmies S., Julkunen H., D'Amato M., Garnier S., Syvänen A. C., Kere J., Variation in STAT4 is associated with systemic Lupus erythematosus in a Finnish family cohort. Annals of the Rheumatic Diseases 2010 69 5 883 886 2-s2.0-77951536271 10.1136/ard.2009.112284
38. Yuan H., Jin-Bao F., Hai-Feng P., A meta-analysis of the association of STAT4 polymorphism with systemic Lupus erythematosus. Modern Rheumatology 2010 20 3 257 262
39. Li P., Cao C., Luan H., Li C., Hu C., Zhang S., Zeng X., Zhang F., Zeng C., Li Y., Association of genetic variations in the STAT4 and IRF7/KIAA1542 regions with systemic Lupus erythematosus in a Northern Han Chinese population. Human Immunology 2011 72 3 249 255 2-s2.0-79651468909 10.1016/j.humimm.2010.12. 011
40. Sigurdsson S., Nordmark G., Garnier S., Grundberg E., Kwan T., Nilsson O., Eloranta M. L., Gunnarsson I., Svenungsson E., Sturfelt G., Bengtsson A. A., Jönsen A., Truedsson L., Rantapää-Dahlqvist S., Eriksson C., Alm G., Göring H. H. H., Pastinen T., Syvänen A. C., Rönnblom L., A risk haplotype of STAT4 for systemic Lupus erythematosus is over-expressed, correlates with anti-dsDNA and shows additive effects with two risk alleles of IRF5. Human Molecular Genetics 2008 17 18 2868 2876 2-s2.0-50849101942 10.1093/hmg/ddn184
41. Cunninghame Graham D. S., Morris D. L., Bhangale T. R., Association of NCF2, IKZF1, IRF8, IFIH1, and TYK2 with systemic Lupus erythematosus. PLoS Genet 2011 7 10 e1002341
42. Graham D. S. C., Akil M., Vyse T. J., Association of polymorphisms across the tyrosine kinase gene, TYK2 in UK SLE families. Rheumatology 2007 46 6 927 930 2-s2.0-34447311899 10.1093/rheumatology/kel449 (Pubitemid 47062497)
43. Ferreiro-Neira I., Calaza M., Alonso-Perez E., Marchini M., Scorza R., Sebastiani G. D., Blanco F. J., Rego I., Pullmann R., Pullmann R., Kallenberg C. G., Bijl M., Skopouli F. N., Mavromati M., Migliaresi S., Barizzone N., Ruzickova S., Dostal C., Schmidt R. E., Witte T., Papasteriades C., Kappou-Rigatou I., Endreffy E., Kovacs A., Ordi-Ros J., Balada E., Carreira P., Gomez-Reino J. J., Gonzalez A., Opposed independent effects and epistasis in the complex association of IRF5 to SLE. Genes and Immunity 2007 8 5 429 438 2-s2.0-34547541897 10.1038/sj.gene.6364407 (Pubitemid 47177133)
44. Taylor P. R., Carugati A., Fadok V. A., Cook H. T., Andrews M., Carroll M. C., Savill J. S., Henson P. M., Botto M., Walport M. J., A hierarchical role for classical pathway complement proteins in the clearance of apoptotic cells in vivo. Journal of Experimental Medicine 2000 192 3 359 366 2-s2.0-0034618113 10.1084/jem.192.3.359 (Pubitemid 30629161)
45. Santer D. M., Wiedeman A. E., Teal T. H., Ghosh P., Elkon K. B., Plasmacytoid dendritic cells and C1q differentially regulate inflammatory gene induction by lupus immune complexes. Journal of Immunology 2012 188 2 902 915
46. Santer D. M., Hall B. E., George T. C., Tangsombatvisit S., Liu C. L., Arkwright P. D., Elkon K. B., C1q deficiency leads to the defective suppression of IFN- α in response to nucleoprotein containing immune complexes. Journal of Immunology 2010 185 8 4738 4749 2-s2.0-78049496573 10.4049/jimmunol.1001731
47. Pickering M. C., Botto M., Taylor P. R., Lachmann P. J., Walport M. J., Systemic Lupus erythematosus, complement deficiency, and apoptosis. Advances in Immunology 2000 76 227 324 2-s2.0-0033752720
48. Walport M. J., Davies K. A., Botto M., C1q and systemic Lupus erythematosus. Immunobiology 1998 199 2 265 285 2-s2.0-0031697215 (Pubitemid 28404347)
49. Chew C. H., Chua K. H., Lian L. H., Puah S. M., Tan S. Y., PCR-RFLP genotyping of C1q mutations and single nucleotide polymorphisms in Malaysian patients with systemic Lupus erythematosus. Human Biology 2008 80 1 83 93 2-s2.0-42649088440 10.3378/1534-6617(2008)80[83:PGOCMA]2.0.CO;2 (Pubitemid 351600434)
50. Yung Yu C., Chung E. K., Yang Y., Blanchong C. A., Jacobsen N., Saxena K., Yang Z., Miller W., Varga L., Fust G., Dancing with Complement C4 and the RP-C4-CYP21-TNX (RCCX) Modules of the Major Histocompatibility Complex. Progress in Nucleic Acid Research and Molecular Biology 2003 75 217 292 2-s2.0-0042209338 10.1016/S0079-6603(03)75007-7 (Pubitemid 137639559)
51. Schifferli J. A., Hauptmann G., Paccaud J. P., Complement-mediated adherence of immune complexes to human erythrocytes. Difference in the requirements for C4A and C4B. FEBS Letters 1987 213 2 415 418 2-s2.0-0023095147 (Pubitemid 17043927)
52. Boteva L., Morris D. L., Cortés-Hernández J., Martin J., Vyse T. J., Fernando M. M., Genetically determined partial complement C4 deficiency states are not independent risk factors for SLE in UK and Spanish populations. The American Journal of Human Genetics 2012 90 3 445 456
53. Yang Y., Chung E. K., Yee L. W., Savelli S. L., Nagaraja H. N., Zhou B., Hebert M., Jones K. N., Shu Y., Kitzmiller K., Blanchong C. A., McBride K. L., Higgins G. C., Rennebohm R. M., Rice R. R., Hackshaw K. V., Roubey R. A. S., Grossman J. M., Tsao B. P., Birmingham D. J., Rovin B. H., Hebert L. A., Yu C. Y., Gene copy-number variation and associated polymorphisms of complement component C4 in human systemic Lupus erythematosus (SLE): low copy number is a risk factor for and high copy number is a protective factor against SLE susceptibility in European Americans. American Journal of Human Genetics 2007 80 6 1037 1054 2-s2.0-34250841166 10.1086/518257 (Pubitemid 47579341)
54. Takai T., Roles of Fc receptors in autoimmunity. Nat Rev Immunol 2002 2 8 580 592 (Pubitemid 37328733)
55. Nimmerjahn F., Activating and inhibitory Fc γ Rs in autoimmune disorders. Springer Seminars in Immunopathology 2006 28 4 305 319 2-s2.0-33845393546 10.1007/s00281-006-0052-1 (Pubitemid 44900570)
56. Sondermann P., Kaiser J., Jacob U., Molecular basis for immune complex recognition: a comparison of Fc-receptor structures. Journal of Molecular Biology 2001 309 3 737 749 2-s2.0-0035827222 10.1006/jmbi.2001.4670 (Pubitemid 32595105)
57. Ceuppens J. L., Baroja M. L., Van Vaeck F., Anderson C. L., Defect in the membrane expression of high affinity 72-kD Fc γ receptors on phagocytic cells in four healthy subjects. Journal of Clinical Investigation 1988 82 2 571 578 2-s2.0-0023678504
58. Dijstelbloem H. M., Kallenberg C. G. M., Van De Winkel J. G. J., Inflammation in autoimmunity: receptors for IgG revisited. Trends in Immunology 2001 22 9 510 516 2-s2.0-0035451391 10.1016/S1471-4906(01)02014-2 (Pubitemid 32778579)
59. Warmerdam P. A. M., Van de Winkel J. G. J., Vlug A., Westerdaal N. A. C., Capel P. J. A., A single amino acid in the second Ig-like domain of the human Fc γ receptor II is critical for human IgG2 binding. Journal of Immunology 1991 147 4 1338 1343 2-s2.0-0025808211
60. Bazilio A. P., Viana V. S. T., Toledo R., Woronik V., Bonfá E., Monteiro R. C., Fc γ RIIa polymorphismml: a susceptibility factor for immune complex-mediated lupus nephritis in Brazilian patients. Nephrology Dialysis Transplantation 2004 19 6 1427 1431 2-s2.0-2942720689 10.1093/ndt/gfh121 (Pubitemid 38786734)
61. Karassa F. B., Trikalinos T. A., Ioannidis J. P. A., Role of the Fc γ receptor IIa polymorphism in susceptibility to systemic Lupus erythematosus and lupus nephritis: a meta-analysis. Arthritis & Rheumatism 2002 46 6 1563 1571 2-s2.0-0035983749 10.1002/art.10306 (Pubitemid 34620203)
62. Yap S. N., Phipps M. E., Manivasagar M., Tan S. Y., Bosco J. J., Human Fc gamma receptor IIA (Fc γ RIIA) genotyping and association with systemic Lupus erythematosus (SLE) in Chinese and Malays in Malaysia. Lupus 1999 8 4 305 310 2-s2.0-0032969678 10.1191/096120399678847876 (Pubitemid 29292096)
63. Karassa F. B., Trikalinos T. A., Ioannidis J. P. A., De Haas M., Edberg J. C., Kimberly R., Koene H. R., Manger K., Salmon J. E., Tsuchiya N., Yoo D. H., The Fc γ RIIIA-F158 allele is a risk factor for the development of lupus nephritis: a meta-analysis. Kidney International 2003 63 4 1475 1482 2-s2.0-0037379229 10.1046/j.1523-1755.2003.00873.x (Pubitemid 36350013)
64. Kyogoku C., Dijstelbloem H. M., Tsuchiya N., Hatta Y., Kato H., Yamaguchi A., Fukazawa T., Jansen M. D., Hashimoto H., Van De Winkel J. G. J., Kallenberg C. G. M., Tokunaga K., Fc γ receptor gene polymorphisms in Japanese patients with systemic Lupus erythematosus: contribution of FCGR2B to genetic susceptibility. Arthritis & Rheumatism 2002 46 5 1242 1254 2-s2.0-0035983742 10.1002/art.10257 (Pubitemid 34525832)
65. Chu Z. T., Tsuchiya N., Kyogoku C., Ohashi J., Qian Y. P., Xu S. B., Mao C. Z., Chu J. Y., Tokunaga K., Association of Fc γ receptor IIb polymorphism with susceptibility to systemic Lupus erythematosus in Chinese: a common susceptibility gene in the Asian populations. Tissue Antigens 2004 63 1 21 27 2-s2.0-1642521645 10.1111/j.1399-0039.2004.00142.x (Pubitemid 38130438)
66. Koene H. R., Kleijer M., Roos D., De Haas M., Von Dem Borne A. E. G. K., Fc γ RIIIB gene duplication: evidence for presence and expression of three distinct Fc γ RIIIB genes in NA(1+,2+)SH(+) individuals. Blood 1998 91 2 673 679 2-s2.0-0031962201 (Pubitemid 28053393)
67. Bredius R. G. M., Fijen C. A. P., De Haas M., Kuijper E. J., Weening R. S., Van de Winkel J. G. J., Out T. A., Role of neutrophil Fc γ RIIa (CD32) and Fc γ RIIIb (CD16) polymorphic forms in phagocytosis of human IgG1- and IgG3-opsonized bacteria and erythrocytes. Immunology 1994 83 4 624 630 2-s2.0-0028171143 (Pubitemid 24374097)
68. Dijstelbloem H. M., Bijl M., Fijnheer R., Fcgamma receptor polymorphisms in systemic Lupus erythematosus: association with disease and in vivo clearance of immune complexes. Arthritis & Rheumatism 2000 43 12 2793 2800 (Pubitemid 32001746)
69. Hatta Y., Tsuchiya N., Ohashi J., Matsushita M., Fujiwara K., Hagiwara K., Juji T., Tokunaga K., Association of Fc γ receptor IIIB, but not of Fc γ receptor IIA and IIIA, polymorphisms with systemic Lupus erythematosus in Japanese. Genes and Immunity 1999 1 1 53 60 2-s2.0-0033188304 (Pubitemid 129622781)
70. Siriboonrit U., Tsuchiya N., Sirikong M., Kyogoku C., Bejrachandra S., Suthipinittharm P., Luangtrakool K., Srinak D., Thongpradit R., Fujiwara K., Chandanayingyong D., Tokunaga K., Association of Fc γ receptor IIb and IIIb polymorphisms with susceptibility to systemic Lupus erythematosus in Thais. Tissue Antigens 2003 61 5 374 383 2-s2.0-0038191047 10.1034/j.1399-0039.2003. 00047.x (Pubitemid 36605670)
71. Hong C. H., The association between fcgammaRIIIB polymorphisms and systemic Lupus erythematosus in Korea. Lupus 2005 14 5 346 350
72. Bolland S., Ravetch J. V., Spontaneous autoimmune disease in Fc γ RIIB-deficient mice results from strain-specific epistasis. Immunity 2000 13 2 277 285 2-s2.0-0033695963
73. McGaha T. L., Sorrentino B., Ravetch J. V., Restoration of tolerance in lupus by targeted inhibitory receptor expression. Science 2005 307 5709 590 593 2-s2.0-12844251399 10.1126/science.1105160 (Pubitemid 40165683)
74. Mackay M., Stanevsky A., Wang T., Selective dysregulation of the FcgammaIIB receptor on memory B cells in SLE. Journal of Experimental Medicine 2006 203 9 2157 2164 (Pubitemid 44352236)
75. Floto R. A., Loss of function of a lupus-associated FcgammaRIIb polymorphism through exclusion from lipid rafts. Nature Medicine 2005 11 10 1056 1058 (Pubitemid 41486826)
76. Bernet J., Mullick J., Singh A. K., Sahu A., Viral mimicry of the complement system. Journal of Biosciences 2003 28 3 249 264 2-s2.0-0037399327 (Pubitemid 36512801)
77. Hom G., Graham R. R., Modrek B., Taylor K. E., Ortmann W., Garnier S., Lee A. T., Chung S. A., Ferreira R. C., Pant P. V. K., Ballinger D. G., Kosoy R., Demirci F. Y., Kamboh M. I., Kao A. H., Tian C., Gunnarsson I., Bengtsson A. A., Rantapää-Dahlqvist S., Petri M., Manzi S., Seldin M. F., Rönnblom L., Syvänen A. C., Criswell L. A., Gregersen P. K., Behrens T. W., Association of systemic Lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX. New England Journal of Medicine 2008 358 9 900 909 2-s2.0-40049108936 10.1056/NEJMoa0707865 (Pubitemid 351397089)
78. Harley J. B., Alarcón-Riquelme M. E., Criswell L. A., Jacob C. O., Kimberly R. P., Moser K. L., Tsao B. P., Vyse T. J., Langefeld C. D., Nath S. K., Guthridge J. M., Cobb B. L., Mirel D. B., Marion M. C., Williams A. H., Divers J., Wang W., Frank S. G., Namjou B., Gabriel S. B., Lee A. T., Gregersen P. K., Behrens T. W., Taylor K. E., Fernando M., Zidovetzki R., Gaffney P. M., Edberg J. C., Rioux J. D., Ojwang J. O., James J. A., Merrill J. T., Gilkeson G. S., Seldin M. F., Yin H., Baechler E. C., Li Q. Z., Wakeland E. K., Bruner G. R., Kaufman K. M., Kelly J. A., Genome-wide association scan in women with systemic Lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci. Nature Genetics 2008 40 2 204 210 2-s2.0-38649125210 10.1038/ng.81 (Pubitemid 351171405)
79. Nath S. K., Han S., Kim-Howard X., Kelly J. A., Viswanathan P., Gilkeson G. S., Chen W., Zhu C., McEver R. P., Kimberly R. P., Alarcón-Riquelme M. E., Vyse T. J., Li Q. Z., Wakeland E. K., Merrill J. T., James J. A., Kaufman K. M., Guthridge J. M., Harley J. B., A nonsynonymous functional variant in integrin- α M (encoded by ITGAM) is associated with systemic Lupus erythematosus. Nature Genetics 2008 40 2 152 154 2-s2.0-38649108122 10.1038/ng.71 (Pubitemid 351171399)
80. Rhodes B., The rs1143679 (R77H) lupus associated variant of ITGAM (CD11b) impairs complement receptor 3 mediated functions in human monocytes. Annals of the Rheumatic Diseases, 2012. In press
81. Kawai T., Akira S., The role of pattern-recognition receptors in innate immunity: update on toll-like receptors. Nature Immunology 2010 11 5 373 384 2-s2.0-77951260924 10.1038/ni.1863
82. Kono D. H., Haraldsson M. K., Lawson B. R., Pollard K. M., Yi T. K., Du X., Arnold C. N., Baccala R., Silverman G. J., Beutler B. A., Theofilopoulos A. N., Endosomal TLR signaling is required for anti-nucleic acid and rheumatoid factor autoantibodies in lupus. Proceedings of the National Academy of Sciences of the United States of America 2009 106 29 12061 12066 2-s2.0-67749135880 10.1073/pnas.0905441106
83. Kang D. C., Gopalkrishnan R. V., Wu Q., Jankowsky E., Pyle A. M., Fisher P. B., mda-5: an interferon-inducible putative RNA helicase with double-stranded RNA-dependent ATPase activity and melanoma growth-suppressive properties. Proceedings of the National Academy of Sciences of the United States of America 2002 99 2 637 642 2-s2.0-0037154176 10.1073/pnas.022637199 (Pubitemid 34106564)
84. Kimkong I., Avihingsanon Y., Hirankarn N., Expression profile of HIN200 in leukocytes and renal biopsy of SLE patients by real-time RT-PCR. Lupus 2009 18 12 1066 1072 2-s2.0-70349503643 10.1177/0961203309106699
85. Yasuda K., Richez C., Maciaszek J. W., Agrawal N., Akira S., Marshak-Rothstein A., Rifkin I. R., Murine dendritic cell type I IFN production induced by human IgG-RNA immune complexes Is IFN regulatory factor (IRF)5 and IRF7 dependent and is required for IL-6 production. Journal of Immunology 2007 178 11 6876 6885 2-s2.0-34249792362 (Pubitemid 46847413)
86. Rifkin I. R., Leadbetter E. A., Busconi L., Viglianti G., Marshak-Rothstein A., Toll-like receptors, endogenous ligands, and systemic autoimmune disease. Immunological Reviews 2005 204 27 42 2-s2.0-16244376480 10.1111/j.0105-2896.2005.00239.x (Pubitemid 40460491)
87. Lövgren T., Eloranta M. L., Kastner B., Wahren-Herlenius M., Alm G. V., Rönnblom L., Induction of interferon- α by immune complexes or liposomes containing systemic Lupus erythematosus autoantigen-and Sjögren's syndrome auto antigen-associated RNA. Arthritis & Rheumatism 2006 54 6 1917 1927 2-s2.0-33745030751 10.1002/art.21893 (Pubitemid 43877941)
88. Lee P. Y., Weinstein J. S., Nacionales D. C., Scumpia P. O., Li Y., Butfiloski E., Van Rooijen N., Moldawer L., Satoh M., Reeves W. H., A novel type i IFN-producing cell subset in murine lupus. Journal of Immunology 2008 180 7 5101 5108 2-s2.0-44449166127
89. Feng D., Stone R. C., Eloranta M. L., Sangster-Guity N., Nordmark G., Sigurdsson S., Wang C., Alm G., Syvänen A. C., Rönnblom L., Barnes B. J., Genetic variants and disease-associated factors contribute to enhanced interferon regulatory factor 5 expression in blood cells of patients with systemic Lupus erythematosus. Arthritis & Rheumatism 2010 62 2 562 573 2-s2.0-75749153301 10.1002/art.27223
90. Obermoser G., Lupus erythematosus and the skin: a journey at times perplexing, usually complex, often challenging, and evermore exhilarating. Lupus 2010 19 9 1009 1011 2-s2.0-77955519934 10.1177/0961203310373108
91. Rönnblom L., Alm G. V., Eloranta M. L., The type I interferon system in the development of lupus. Seminars in Immunology 2011 23 2 113 121 2-s2.0-79953161285 10.1016/j.smim.2011.01.009
92. Crow M. K., Type I interferon in organ-targeted autoimmune and inflammatory diseases. Arthritis Research & Therapy 2010 12 S5 2-s2.0-79955694610
93. Baechler E. C., Batliwalla F. M., Karypis G., Gaffney P. M., Ortmann W. A., Espe K. J., Shark K. B., Grande W. J., Hughes K. M., Kapur V., Gregersen P. K., Behrens T. W., Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proceedings of the National Academy of Sciences of the United States of America 2003 100 5 2610 2615 2-s2.0-0344492212 10.1073/pnas.0337679100 (Pubitemid 36297546)
94. Kozyrev S. V., Alarcon-Riquelme M. E., The genetics and biology of Irf5-mediated signaling in lupus. Autoimmunity 2007 40 8 591 601 2-s2.0-37349039478 10.1080/08916930701510905 (Pubitemid 350302184)
95. Smith S., Gabhann J. N., Higgs R., Enhanced interferon regulatory factor 3 binding to the interleukin-23p19 promoter correlates with enhanced interleukin-23 expression in systemic Lupus erythematosus. Arthritis & Rheumatism 2012 64 5 1601 1609
96. Stone R. C., Interferon regulatory factor 5 activation in monocytes of systemic Lupus erythematosus patients is triggered by circulating autoantigens independent of type I interferons. Arthritis & Rheumatism 2012 64 3 788 798
97. Graham R. R., Kyogoku C., Sigurdsson S., Vlasova I. A., Davies L. R. L., Baechler E. C., Plenge R. M., Koeuth T., Ortmann W. A., Hom G., Bauer J. W., Gillett C., Burtt N., Graham D. S. C., Onofrio R., Petri M., Gunnarsson I., Svenungsson E., Rönnblom L., Nordmark G., Gregersen P. K., Moser K., Gaffney P. M., Criswell L. A., Vyse T. J., Syvänen A. C., Bohjanen P. R., Daly M. J., Behrens T. W., Altshuler D., Three functional variants of IFN regulatory factor 5 (IRF5) define risk and protective haplotypes for human lupus. Proceedings of the National Academy of Sciences of the United States of America 2007 104 16 6758 6763 2-s2.0-34249860408 10.1073/pnas.0701266104 (Pubitemid 47175574)
98. Christensen S. R., Shupe J., Nickerson K., Kashgarian M., Flavell R., Shlomchik M. J., Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of Lupus. Immunity 2006 25 3 417 428 2-s2.0-33748472865 10.1016/j.immuni.2006.07.013 (Pubitemid 44354217)
99. Pisitkun P., Deane J. A., Difilippantonio M. J., Tarasenko T., Satterthwaite A. B., Bolland S., Autoreactive B cell responses to RNA-related antigens due to TLR7 gene duplication. Science 2006 312 5780 1669 1672 2-s2.0-33745168605 10.1126/science.1124978 (Pubitemid 43902669)
100. Subramanian S., Tus K., Li Q. Z., Wang A., Tian X. H., Zhou J., Liang C., Bartov G., McDaniel L. D., Zhou X. J., Schultz R. A., Wakeland E. K., A Tlr7 translocation accelerates systemic autoimmunity in murine lupus. Proceedings of the National Academy of Sciences of the United States of America 2006 103 26 9970 9975 2-s2.0-33745617886 10.1073/pnas.0603912103 (Pubitemid 43993607)
101. Deane J. A., Pisitkun P., Barrett R. S., Feigenbaum L., Town T., Ward J., Flavell R. A., Bolland S., Control of Toll-like receptor 7 expression is essential to restrict autoimmunity and dendritic cell proliferation. Immunity 2007 27 5 801 810 2-s2.0-36048962438 10.1016/j.immuni.2007.09.009 (Pubitemid 350102256)
102. Deng Y., Zhao J., Tan W., Association of variants in the TLR7-TLR8 region with systemic Lupus erythematosus in non-asian populations. Arthritis & Rheumatism 2010 62, supplement 10 1584
103. Sánchez E., Callejas-Rubio J. L., Sabio J. M., Investigation of TLR5 and TLR7 as candidate genes for susceptibility to systemic Lupus erythematosus. Clinical and Experimental Rheumatology 2009 27 2 267 271
104. García-Ortiz H., Velázquez-Cruz R., Espinosa-Rosales F., Jiménez-Morales S., Baca V., Orozco L., Association of TLR7 copy number variation with susceptibility to childhood-onset systemic Lupus erythematosus in Mexican population. Annals of the Rheumatic Diseases 2010 69 10 1861 1865 2-s2.0-77957282676 10.1136/ard.2009.124313
105. Papadimitraki E. D., Choulaki C., Koutala E., Bertsias G., Tsatsanis C., Gergianaki I., Raptopoulou A., Kritikos H. D., Mamalaki C., Sidiropoulos P., Boumpas D. T., Expansion of toll-like receptor 9-expressing B cells in active systemic Lupus erythematosus: implications for the induction and maintenance of the autoimmune process. Arthritis & Rheumatism 2006 54 11 3601 3611 2-s2.0-33750953650 10.1002/art.22197 (Pubitemid 44737172)
106. Wu X., Peng S. L., Toll-like receptor 9 signaling protects against murine lupus. Arthritis & Rheumatism 2006 54 1 336 342 2-s2.0-31044440025 10.1002/art.21553 (Pubitemid 43122217)
107. Ng M. W., Lau C. S., Chan T. M., Wong W. H. S., Lau Y. L., Polymorphisms of the toll-like receptor 9 (TLR9) gene with systemic Lupus erythematosus in Chinese [1]. Rheumatology 2005 44 11 1456 1457 2-s2.0-27744509806 10.1093/rheumatology/kei120 (Pubitemid 41631873)
108. Demirci F. Y. K., Manzi S., Ramsey-Goldman R., Kenney M., Shaw P. S., Dunlop-Thomas C. M., Kao A. H., Rhew E. Y., Bontempo F., Kammerer C., Kamboh M. I., Association study of Toll-like Receptor 5 (TLR5) and Toll-like Receptor 9 (TLR9) polymorphisms in systemic Lupus erythematosus. Journal of Rheumatology 2007 34 8 1708 1711 2-s2.0-34547946205 (Pubitemid 47267614)
109. Ganguly D., Chamilos G., Lande R., Gregorio J., Meller S., Facchinetti V., Homey B., Barrat F. J., Zal T., Gilliet M., Self-RNA-antimicrobial peptide complexes activate human dendritic cells through TLR7 and TLR8. Journal of Experimental Medicine 2009 206 9 1983 1994 2-s2.0-69549135324 10.1084/jem.20090480
110. Lamphier M. S., Sirois C. M., Verma A., Golenbock D. T., Latz E., TLR9 and the recognition of self and non-self nucleic acids. Annals of the New York Academy of Sciences 2006 1082 31 43 2-s2.0-33845636049 10.1196/annals.1348.005 (Pubitemid 44955446)
111. Gaffney P. M., Kearns G. M., Shark K. B., Ortmann W. A., Selby S. A., Malmgren M. L., Rohlf K. E., Ockenden T. C., Messner R. P., King R. A., Rich S. S., Behrens T. W., A genome-wide search for susceptibility genes in human systemic Lupus erythematosus sib-pair families. Proceedings of the National Academy of Sciences of the United States of America 1998 95 25 14875 14879 2-s2.0-4243900858 10.1073/pnas.95.25.14875 (Pubitemid 29003724)
112. Shai R., Quismorio F. P., Li L., Kwon O. J., Morrison J., Wallace D. J., Neuwelt C. M., Brautbar C., Gauderman W. J., Jacob C. O., Genome-wide screen for systemic Lupus erythematosus susceptibility genes in multiplex families. Human Molecular Genetics 1999 8 4 639 644 2-s2.0-0033029712 (Pubitemid 29139978)
113. Kyogoku C., Tsuchiya N., A compass that points to lupus: genetic studies on type I interferon pathway. Genes and Immunity 2007 8 6 445 455 2-s2.0-34548433979 10.1038/sj.gene.6364409 (Pubitemid 47365611)
114. Kawasaki A., Ito I., Ito S., Hayashi T., Goto D., Matsumoto I., Takasaki Y., Hashimoto H., Sumida T., Tsuchiya N., Association of TNFAIP3 polymorphism with susceptibility to systemic Lupus erythematosus in a Japanese population. Journal of Biomedicine and Biotechnology 2010 2010 2-s2.0-77953501119 10.1155/2010/207578 207578
115. Cao Z., Xiong J., Takeuchi M., Kurama T., Goeddel D. V., TRAF6 is a signal transducer for interleukin-1. Nature 1996 383 6599 443 446 2-s2.0-0029761275 10.1038/383443a0 (Pubitemid 26330834)
116. Sandling J. K., Garnier S., Sigurdsson S., Wang C., Nordmark G., Gunnarsson I., Svenungsson E., Padyukov L., Sturfelt G., Jönsen A., Bengtsson A. A., Truedsson L., Eriksson C., Rantapää-Dahlqvist S., Mälarstig A., Strawbridge R. J., Hamsten A., Criswell L. A., Graham R. R., Behrens T. W., Eloranta M. L., Alm G., Rönnblom L., Syvänen A. C., A candidate gene study of the type i interferon pathway implicates IKBKE and IL8 as risk loci for SLE. European Journal of Human Genetics 2011 19 4 479 484 2-s2.0-79952773104 10.1038/ejhg.2010.197
117. Stetson D. B., Ko J. S., Heidmann T., Medzhitov R., Trex1 prevents cell-intrinsic initiation of autoimmunity. Cell 2008 134 4 587 598 2-s2.0-49549100511 10.1016/j.cell.2008.06.032
118. Crow Y. J., Rehwinkel J., Aicardi-Goutieres syndrome and related phenotypes: linking nucleic acid metabolism with autoimmunity. Human Molecular Genetics 2009 18 2 R130 136 2-s2.0-77950400643
119. Aicardi J., Goutieres F., Systemic Lupus erythematosus or Aicardi-Goutieres syndrome? Neuropediatrics 2000 31 3 113 2-s2.0-0033928560 10.1055/s-2000-7533 (Pubitemid 30495433)
120. Rice G., Newman W. G., Dean J., Patrick T., Parmar R., Flintoff K., Robins P., Harvey S., Hollis T., O'Hara A., Herrick A. L., Bowden A. P., Perrino F. W., Lindahl T., Barnes D. E., Crow Y. J., Heterozygous mutations in TREX1 cause familial chilblain lupus and dominant Aicardi-Goutières syndrome. American Journal of Human Genetics 2007 80 4 811 815 2-s2.0-34147185679 10.1086/513443 (Pubitemid 46564418)
121. Lee-Kirsch M. A., Gong M., Chowdhury D., Senenko L., Engel K., Lee Y. A., De Silva U., Bailey S. L., Witte T., Vyse T. J., Kere J., Pfeiffer C., Harvey S., Wong A., Koskenmies S., Hummel O., Rohde K., Schmidt R. E., Dominiczak A. F., Gahr M., Hollis T., Perrino F. W., Lieberman J., Hübner N., Mutations in the gene encoding the 3′-5′ DNA exonuclease TREX1 are associated with systemic Lupus erythematosus. Nature Genetics 2007 39 9 1065 1067 2-s2.0-34548327158 10.1038/ng2091 (Pubitemid 47340647)
122. Crow Y. J., Hayward B. E., Parmar R., Robins P., Leitch A., Ali M., Black D. N., Van Bokhoven H., Brunner H. G., Hamel B. C., Corry P. C., Cowan F. M., Frints S. G., Klepper J., Livingston J. H., Lynch S. A., Massey R. F., Meritet J. F., Michaud J. L., Ponsot G., Voit T., Lebon P., Bonthron D. T., Jackson A. P., Barnes D. E., Lindahl T., Mutations in the gene encoding the 3′-5′ DNA exonuclease TREX1 cause Aicardi-Goutières syndrome at the AGS1 locus. Nature Genetics 2006 38 8 917 920 2-s2.0-33746581694 10.1038/ng1845 (Pubitemid 44141660)
123. Lehtinen D. A., Harvey S., Mulcahy M. J., Hollis T., Perrino F. W., The TREX1 double-stranded DNA degradation activity is defective in dominant mutations associated with autoimmune disease. Journal of Biological Chemistry 2008 283 46 31649 31656 2-s2.0-57649134251 10.1074/jbc.M806155200
124. Fye J. M., Orebaugh C. D., Coffin S. R., Dominant mutation of the TREX1 exonuclease gene in lupus and Aicardi-Goutieres syndrome. Journal of Biological Chemistry 2011 286 37 32373 32382
125. Demirci F. Y. K., Manzi S., Ramsey-Goldman R., Minster R. L., Kenney M., Shaw P. S., Dunlop-Thomas C. M., Kao A. H., Rhew E., Bontempo F., Kammerer C., Kamboh M. I., Association of a Common Interferon Regulatory Factor 5 (IRF5) variant with increased risk of Systemic Lupus erythematosus (SLE). Annals of Human Genetics 2007 71 3 308 311 2-s2.0-34247162727 10.1111/j.1469-1809.2006. 00336.x (Pubitemid 46585673)
126. Graham D. S. C., Manku H., Wagner S., Reid J., Timms K., Gutin A., Lanchbury J. S., Vyse T. J., Association of IRF5 in UK SLE families identifies a variant involved in polyadenylation. Human Molecular Genetics 2007 16 6 579 591 2-s2.0-34247125683 10.1093/hmg/ddl469 (Pubitemid 46585660)
127. Kawasaki A., Kyogoku C., Ohashi J., Miyashita R., Hikami K., Kusaoi M., Tokunaga K., Takasaki Y., Hashimoto H., Behrens T. W., Tsuchiya N., Association of IRF5 polymorphisms with systemic Lupus erythematosus in a Japanese population: support for a crucial role of intron 1 polymorphisms. Arthritis & Rheumatism 2008 58 3 826 834 2-s2.0-40549100665 10.1002/art.23216 (Pubitemid 351364880)
128. Siu H. O., Yang W., Lau C. S., Chan T. M., Wong R. W. S., Wong W. H. S., Lau Y. L., Alarcon-Riquelme M. E., Association of a haplotype of IRF5 gene with systemic Lupus erythematosus in Chinese. Journal of Rheumatology 2008 35 2 360 362 2-s2.0-39549092431 (Pubitemid 351281165)
129. Graham R. R., Hom G., Ortmann W., Behrens T. W., Review of recent genome-wide association scans in lupus. Journal of Internal Medicine 2009 265 6 680 688 2-s2.0-66149083275 10.1111/j.1365-2796.2009.02096.x
130. Sigurdsson S., Göring H. H. H., Kristjansdottir G., Milani L., Nordmark G., Sandling J. K., Eloranta M. L., Feng D., Sangster-Guity N., Gunnarsson I., Svenungsson E., Sturfelt G., Jönsen A., Truedsson L., Barnes B. J., Alm G., Rönnblom L., Syvänen A. C., Comprehensive evaluation of the genetic variants of interferon regulatory factor 5 (IRF5) reveals a novel 5 bp length polymorphism as strong risk factor for systemic Lupus erythematosus. Human Molecular Genetics 2008 17 6 872 881 2-s2.0-40649121122 10.1093/hmg/ddm359 (Pubitemid 351368993)
131. Miceli-Richard C., Gestermann N., Ittah M., Comets E., Loiseau P., Puechal X., Hachulla E., Gottenberg J. E., Lebon P., Becquemont L., Mariette X., The CGGGG insertion/deletion polymorphism of the IRF5 promoter is a strong risk factor for primary Sjögren's syndrome. Arthritis & Rheumatism 2009 60 7 1991 1997 2-s2.0-67650074526 10.1002/art.24662
132. Kristjansdottir G., Sandling J. K., Bonetti A., Roos I. M., Milani L., Wang C., Gustafsdottir S. M., Sigurdsson S., Lundmark A., Tienari P. J., Koivisto K., Elovaara I., Pirttilä T., Reunanen M., Peltonen L., Saarela J., Hillert J., Olsson T., Landegren U., Alcina A., Fernández O., Leyva L., Guerrero M., Lucas M., Izquierdo G., Matesanz F., Syvänen A. C., Interferon regulatory factor 5 (IRF5) gene variants are associated with multiple sclerosis in three distinct populations. Journal of Medical Genetics 2008 45 6 362 369 2-s2.0-45249112573 10.1136/jmg.2007.055012 (Pubitemid 351839477)
133. Dideberg V., Kristjansdottir G., Milani L., Libioulle C., Sigurdsson S., Louis E., Wiman A. C., Vermeire S., Rutgeerts P., Belaiche J., Franchimont D., Van gossum A., Bours V., Syvänen A. C., An insertion-deletion polymorphism in the Interferon Regulatory Factor 5 (IRF5) gene confers risk of inflammatory bowel diseases. Human Molecular Genetics 2007 16 24 3008 3016 2-s2.0-36249002287 10.1093/hmg/ddm259 (Pubitemid 350131319)
134. Hedl M., Abraham C., IRF5 risk polymorphisms contribute to interindividual variance in pattern recognition receptor-mediated cytokine secretion in human monocyte-derived cells. The Journal of Immunology 2012 188 11 5348 5356
135. Niewold T. B., Kelly J. A., Flesch M. H., Espinoza L. R., Harley J. B., Crow M. K., Association of the IRF5 risk haplotype with high serum interferon- α activity in systemic Lupus erythematosus patients. Arthritis & Rheumatism 2008 58 8 2481 2487 2-s2.0-49449104525 10.1002/art.23613
136. Lövgren T., Eloranta M. L., Båve U., Alm G. V., Rönnblom L., Induction of interferon- α production in plasmacytoid dendritic cells by immune complexes containing nucleic acid released by necrotic or late apoptotic cells and lupus IgG. Arthritis & Rheumatism 2004 50 6 1861 1872 2-s2.0-2642528779 10.1002/art.20254 (Pubitemid 38725099)
137. Niewold T. B., Kelly J. A., Kariuki S. N., IRF5 haplotypes demonstrate diverse serological associations which predict serum interferon alpha activity and explain the majority of the genetic association with systemic Lupus erythematosus. Annals of the Rheumatic Diseases 2012 71 3 463 469
138. Honda K., Yanai H., Negishi H., Asagiri M., Sato M., Mizutani T., Shimada N., Ohba Y., Takaoka A., Yoshida N., Taniguchi T., IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature 2005 434 7034 772 777 2-s2.0-17144404177 10.1038/nature03464 (Pubitemid 44739521)
139. Salloum R., Franek B. S., Kariuki S. N., Rhee L., Mikolaitis R. A., Jolly M., Utset T. O., Niewold T. B., Genetic variation at the IRF7/PHRF1 locus is associated with autoantibody profile and serum interferon- α activity in lupus patients. Arthritis & Rheumatism 2010 62 2 553 561 2-s2.0-75749110600 10.1002/art.27182
140. Lee E. G., Boone D. L., Chai S., Libby S. L., Chien M., Lodolce J. P., Ma A., Failure to regulate TNF-induced NF- B and cell death responses in A20-deficient mice. Science 2000 289 5488 2350 2354 2-s2.0-0034730713 10.1126/science.289.5488.2350
141. Dixit V. M., Green S., Sarma V., Holzman L. B., Wolf F. W., O'Rourke K., Ward P. A., Prochownik E. V., Marks R. M., Tumor necrosis factor- α induction of novel gene products in human endothelial cells including a macrophage-specific chemotaxin. Journal of Biological Chemistry 1990 265 5 2973 2978 2-s2.0-0025271844
142. Opipari A. W., Boguski M. S., Dixit V. M., The A20 cDNA induced by tumor necrosis factor α encodes a novel type of zinc finger protein. Journal of Biological Chemistry 1990 265 25 14705 14708 2-s2.0-0025179989
143. Ning S., Pagano J. S., The A20 deubiquitinase activity negatively regulates LMP1 activation of IRF7. Journal of Virology 2010 84 12 6130 6138 2-s2.0-77952716624 10.1128/JVI.00364-10
144. Graham R. R., Cotsapas C., Davies L., Hackett R., Lessard C. J., Leon J. M., Burtt N. P., Guiducci C., Parkin M., Gates C., Plenge R. M., Behrens T. W., Wither J. E., Rioux J. D., Fortin P. R., Cunninghame Graham D., Wong A. K., Vyse T. J., Daly M. J., Altshuler D., Moser K. L., Gaffney P. M., Genetic variants near TNFAIP3 on 6q23 are associated with systemic Lupus erythematosus. Nature Genetics 2008 40 9 1059 1061 2-s2.0-50449111452 10.1038/ng.200
145. Shimane K., Kochi Y., Horita T., Ikari K., Amano H., Hirakata M., Okamoto A., Yamada R., Myouzen K., Suzuki A., Kubo M., Atsumi T., Koike T., Takasaki Y., Momohara S., Yamanaka H., Nakamura Y., Yamamoto K., The association of a nonsynonymous single-nucleotide polymorphism in TNFAIP3 with systemic Lupus erythematosus and rheumatoid arthritis in the japanese population. Arthritis & Rheumatism 2010 62 2 574 579 2-s2.0-75749156268 10.1002/art.27190
146. Adrianto I., Wen F., Templeton A., Wiley G., King J. B., Lessard C. J., Bates J. S., Hu Y., Kelly J. A., Kaufman K. M., Guthridge J. M., Alarcón-Riquelme M. E., Anaya J. M., Bae S. C., Bang S. Y., Boackle S. A., Brown E. E., Petri M. A., Gallant C., Ramsey-Goldman R., Reveille J. D., Vila L. M., Criswell L. A., Edberg J. C., Freedman B. I., Gregersen P. K., Gilkeson G. S., Jacob C. O., James J. A., Kamen D. L., Kimberly R. P., Martin J., Merrill J. T., Niewold T. B., Park S. Y., Pons-Estel B. A., Scofield R. H., Stevens A. M., Tsao B. P., Vyse T. J., Langefeld C. D., Harley J. B., Moser K. L., Webb C. F., Humphrey M. B., Montgomery C. G., Gaffney P. M., Association of a functional variant downstream of TNFAIP3 with systemic Lupus erythematosus. Nature Genetics 2011 43 3 253 258 2-s2.0-79952192654 10.1038/ng.766
147. Mauro C., Pacifico F., Lavorgna A., ABIN-1 binds to NEMO/IKKgamma and co-operates with A20 in inhibiting NF-kappaB. Journal of Biological Chemistry 2006 281 27 18482 18488 (Pubitemid 44035507)
148. Kawasaki A., Ito S., Furukawa H., Hayashi T., Goto D., Matsumoto I., Kusaoi M., Ohashi J., Graham R. R., Matsuta K., Behrens T. W., Tohma S., Takasaki Y., Hashimoto H., Sumida T., Tsuchiya N., Association of TNFAIP3 interacting protein 1, TNIP1 with systemic Lupus erythematosus in a Japanese population: a case-control association study. Arthritis research & therapy 2010 12 5 R174 2-s2.0-79952732407
149. Ronnblom L. E., Alm G. V., Oberg K. E., Autoimmunity after alpha-interferon therapy for malignant carcinoid tumors. Annals of Internal Medicine 1991 115 3 178 183 2-s2.0-0025911863
150. Ronnblom L. E., Alm G. V., Oberg K., Autoimmune phenomena in patients with malignant carcinoid tumors during interferon- α treatment. Acta Oncologica 1991 30 4 537 540 2-s2.0-0025916262
151. O'Shea J.J., Plenge R., JAK and STAT signaling molecules in immunoregulation and immune-mediated disease. Immunity 2012 36 4 542 550
152. Hervas-Stubbs S., Perez-Gracia J. L., Rouzaut A., Sanmamed M. F., Le Bon A., Melero I., Direct effects of type I interferons on cells of the immune system. Clinical Cancer Research 2011 17 9 2619 2627 2-s2.0-79955509835 10.1158/1078-0432.CCR-10-1114
153. Korman B. D., Kastner D. L., Gregersen P. K., Remmers E. F., STAT4: genetics, mechanisms, and implications for autoimmunity. Current allergy and asthma reports 2008 8 5 398 403 2-s2.0-55249101270 10.1007/s11882-008-0077-8
154. Jacob C. O., Zang S., Li L., Ciobanu V., Quismorio F., Mizutani A., Satoh M., Koss M., Pivotal role of Stat4 and Stat6 in the pathogenesis of the lupus-like disease in the New Zealand mixed 2328 mice. Journal of Immunology 2003 171 3 1564 1571 2-s2.0-0041344320 (Pubitemid 36900092)
155. Sigurdsson S., Nordmark G., Garnier S., Grundberg E., Kwan T., Nilsson O., Eloranta M. L., Gunnarsson I., Svenungsson E., Sturfelt G., Bengtsson A. A., Jönsen A., Truedsson L., Rantapää-Dahlqvist S., Eriksson C., Alm G., Göring H. H. H., Pastinen T., Syvänen A. C., Rönnblom L., A risk haplotype of STAT4 for systemic Lupus erythematosus is over-expressed, correlates with anti-dsDNA and shows additive effects with two risk alleles of IRF5. Human Molecular Genetics 2008 17 18 2868 2876 2-s2.0-50849101942 10.1093/hmg/ddn184
156. Honda K., Yanai H., Takaoka A., Taniguchi T., Regulation of the type I IFN induction: a current view. International Immunology 2005 17 11 1367 1378 2-s2.0-27744526416 10.1093/intimm/dxh318 (Pubitemid 41631313)
157. Lee Y. H., Choi S. J., Ji J. D., Song G. G., Associations between PXK and TYK2 polymorphisms and systemic lupus erythematosus: a meta-analysis. Inflammation Research 2012 61 9 949 954
158. Richter M. F., Duménil G., Uzé G., Fellous M., Pellegrini S., Specific contribution of Tyk2 JH regions to the binding and the expression of the interferon α / β receptor component IFNAR1. Journal of Biological Chemistry 1998 273 38 24723 24729 2-s2.0-0032544656 10.1074/jbc.273.38.24723 (Pubitemid 28454973)
159. Ragimbeau J., Dondi E., Alcover A., Eid P., Uzé G., Pellegrini S., The tyrosine kinase Tyk2 controls IFNAR1 cell surface expression. EMBO Journal 2003 22 3 537 547 2-s2.0-0037415720 10.1093/emboj/cdg038 (Pubitemid 36193598)
160. Teh B. K., Yeo J. G., Chern L. M., Lu J., C1q regulation of dendritic cell development from monocytes with distinct cytokine production and T cell stimulation. Molecular Immunology 2011 48 9-10 1128 1138 2-s2.0-79954585737 10.1016/j.molimm.2011.02.006
161. Kariuki S. N., Franek B. S., Kumar A. A., Arrington J., Mikolaitis R. A., Utset T. O., Jolly M., Crow M. K., Skol A. D., Niewold T. B., Trait-stratified genome-wide association study identifies novel and diverse genetic associations with serologic and cytokine phenotypes in systemic Lupus erythematosus. Arthritis Research and Therapy 2010 12 4, article R151 2-s2.0-77954877255 10.1186/ar3101
162. Koldobskaya Y., Ko K., Kumar A. A., Gene-expression-guided selection of candidate Loci and molecular phenotype analyses enhance genetic discovery in systemic lupus erythematosus. Clinical and Developmental Immunology 2012 2012 9 10.1155/2012/682018 682018